NRC
BSX icon

New Republic Capital’s Boston Scientific BSX Stock Holding History

New Republic Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,059
Closed -$387K – 324
2025
Q4 		$387K Buy
4,059
+1,829
+82% +$179K 0.1% 178
2025
Q3 		$218K Buy
2,230
+25
+1% +$2.59K 0.07% 177
2025
Q2 		$237K Buy
+2,205
New +$223K 0.08% 160

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

New Republic Capital's BSX Position: Q1 2026 in Review

New Republic Capital sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 4,059 shares — an estimated $387K sold.

New Republic Capital first reported a position in BSX in Q2 2025 and held it in 3 quarters. The position peaked at $387K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • New Republic Capital reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • New Republic Capital sold 4,059 Boston Scientific shares in Q1 2026, an estimated $387K.
  • New Republic Capital first reported a position in Boston Scientific in Q2 2025 and held it in 3 quarters.
  • New Republic Capital's Boston Scientific position peaked at $387K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on New Republic Capital's 13F filing for Q1 2026, filed 1 May 2026.